Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $6.9 Million - $7.59 Million
-94,953 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $2.78 Million - $3.34 Million
45,275 Added 91.14%
94,953 $6.93 Million
Q4 2021

Feb 01, 2022

BUY
$53.63 - $62.52 $63,390 - $73,898
1,182 Added 2.44%
49,678 $3.1 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $63,829 - $69,510
1,031 Added 2.17%
48,496 $3.24 Million
Q4 2020

Feb 08, 2021

BUY
$57.74 - $65.43 $2,598 - $2,944
45 Added 0.09%
47,465 $2.94 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $32,964 - $36,529
574 Added 1.23%
47,420 $2.86 Million
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $86,999 - $101,710
1,587 Added 3.51%
46,846 $2.76 Million
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $29,928 - $43,492
645 Added 1.45%
45,259 $2.52 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $19,437 - $25,355
395 Added 0.89%
44,614 $2.86 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $36,268 - $43,002
848 Added 1.96%
44,219 $2.24 Million
Q2 2019

Jul 30, 2019

BUY
$44.62 - $49.34 $485,599 - $536,967
10,883 Added 33.5%
43,371 $1.97 Million
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $97,323 - $116,046
2,157 Added 7.11%
32,488 $1.55 Million
Q4 2018

Feb 08, 2019

BUY
$48.76 - $63.23 $35,741 - $46,347
733 Added 2.48%
30,331 $1.58 Million
Q3 2018

Nov 07, 2018

BUY
$55.19 - $62.25 $26,987 - $30,440
489 Added 1.68%
29,598 $1.84 Million
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $34,107 - $42,511
675 Added 2.37%
29,109 $1.61 Million
Q1 2018

May 04, 2018

BUY
$59.92 - $68.98 $31,158 - $35,869
520 Added 1.86%
28,434 $1.8 Million
Q4 2017

Feb 07, 2018

BUY
$59.94 - $65.35 $45,194 - $49,273
754 Added 2.78%
27,914 $1.71 Million
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $1.5 Million - $1.73 Million
27,160
27,160 $1.73 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Agf Investments America Inc. Portfolio

Follow Agf Investments America Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments America Inc., based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments America Inc. with notifications on news.